These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 10722503

  • 21. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.
    Ma L, Ishii Y, Chang FY, Yamaguchi K, Ho M, Siu LK.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1985-8. PubMed ID: 12019121
    [Abstract] [Full Text] [Related]

  • 22. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A, Schönling J, Melzer B, Warnatz K, Leusch HG.
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [Abstract] [Full Text] [Related]

  • 23. Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing beta-lactamase from Chryseobacterium gleum.
    Bellais S, Naas T, Nordmann P.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2791-6. PubMed ID: 12183230
    [Abstract] [Full Text] [Related]

  • 24. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
    Rasmussen BA, Keeney D, Yang Y, Bush K.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022
    [Abstract] [Full Text] [Related]

  • 25. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y, Wachino J, Ishiguro M, Kurokawa H, Yamane K, Shibata N, Shibayama K, Yokoyama K, Kato H, Yagi T, Arakawa Y.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [Abstract] [Full Text] [Related]

  • 26. Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India.
    Aubert D, Girlich D, Naas T, Nagarajan S, Nordmann P.
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3284-90. PubMed ID: 15328086
    [Abstract] [Full Text] [Related]

  • 27. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E, Gibbs M, Clouting C, Barker L, Clifton-Hadley FA, Pleydell E, Abdalhamid B, Hanson ND, Martin L, Poppe C, Davies RH.
    Microb Drug Resist; 2004 Sep; 10(1):1-9. PubMed ID: 15140388
    [Abstract] [Full Text] [Related]

  • 28. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.
    Oliver A, Pérez-Díaz JC, Coque TM, Baquero F, Cantón R.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):616-20. PubMed ID: 11158766
    [Abstract] [Full Text] [Related]

  • 29. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH.
    J Appl Microbiol; 2005 Feb; 98(4):921-7. PubMed ID: 15752339
    [Abstract] [Full Text] [Related]

  • 30. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A, Maharjan S, Gaulton T, Doumith M, Soares NC, Dhanji H, Warner M, Doyle M, Hickey M, Downie G, Bou G, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [Abstract] [Full Text] [Related]

  • 31. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S, Kuzucu Ç, Otlu B, Yetkin F, Ersoy Y.
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [Abstract] [Full Text] [Related]

  • 32. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H, Poirel L, Nordmann P.
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [Abstract] [Full Text] [Related]

  • 33. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Hall LM, Livermore DM, Gur D, Akova M, Akalin HE.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
    [Abstract] [Full Text] [Related]

  • 34. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J, Králiková K, Krcméry V, Schäfer V.
    J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
    [Abstract] [Full Text] [Related]

  • 35. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK, Lee YN, Hwang HY, Jeong SH, Lee SJ, Kwak HS, Song W, Kim HJ, Youn H.
    J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
    [Abstract] [Full Text] [Related]

  • 36. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.
    Bou G, Oliver A, Ojeda M, Monzón C, Martínez-Beltrán J.
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2549-53. PubMed ID: 10952615
    [Abstract] [Full Text] [Related]

  • 37. EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis.
    Bellais S, Girlich D, Karim A, Nordmann P.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3223-7. PubMed ID: 12234848
    [Abstract] [Full Text] [Related]

  • 38. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
    Bradford PA, Jacobus NV, Bhachech N, Bush K.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):260-2. PubMed ID: 8787920
    [Abstract] [Full Text] [Related]

  • 39. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.
    Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K.
    Antimicrob Agents Chemother; 1995 Apr; 39(4):899-905. PubMed ID: 7785992
    [Abstract] [Full Text] [Related]

  • 40. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ, Marriott MS, Amyes SG.
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.